Add BrightSurf on Google Email

Recent advances in the diagnosis and treatment of fat accumulation in liver and pancreas

Researchers highlight latest developments in pathology, diagnosis, and treatment of MASLD and IPFD, revealing correlations with chronic diseases like liver cancer and pancreatic cancer. Innovative treatments, such as AI-driven approaches and organ-targeted therapies, show promise for precision prevention and therapy.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalPortal Hypertension & Cirrhosis·TypeSystematic review·DateJun 1, 2026

SNMMI Abstract of the Year: PET imaging links brain metabolism patterns to effectiveness of Alzheimer's disease treatment

A study found that a specific pattern of brain metabolism visualized with PET imaging can predict which patients are most likely to benefit from Alzheimer's disease therapy. Patients with this pattern experienced stabilized cognitive performance, while those with other patterns had significant cognitive decline.

New SPECT imaging approach distinguishes inflammation from fibrosis to optimize treatment for lung disease

A new SPECT/CT imaging approach can accurately differentiate between inflammation and fibrosis in interstitial lung disease (ILD) patients. Researchers used the molecular imaging agent ⁹⁹ᵐTc-maraciclatide to visualize inflammation, which is crucial for determining treatment decisions.

SourceSociety of Nuclear Medicine and Molecular Imaging·JournalJournal of Nuclear Medicine·DateMay 31, 2026

Shannon Youngblood, EdD, MSRS, CNMT, RT(CT)(ARRT), takes office as president of the SNMMI Technologist Section

Shannon Youngblood has been elected as the new president of the SNMMI Technologist Section. She will focus on amplifying visibility through advocacy, building a more inclusive workforce through educational opportunities, and streamlining professional development to stay current with advancements in theranostics and cardiac PET-CT.

Dual PET imaging detects tumor progression and heart inflammation during cancer treatment

Researchers developed a novel PET imaging approach to detect immune-related adverse events in patients receiving immunotherapy. The approach uses CCR2-targeted radiotracer to visualize both tumor progression and cardiac inflammatory responses. Co-treatment with itacitinib improved tumor response while reducing cardiac inflammation.

SourceSociety of Nuclear Medicine and Molecular Imaging·JournalJournal of Nuclear Medicine·DateMay 31, 2026

Richard E. Carson, Ph.D., receives SNMMI 2026 Paul C. Aebersold Award for Outstanding Achievement in Basic Nuclear Medicine Science

Dr. Richard E. Carson has made significant contributions to the understanding and application of nuclear medicine, particularly in neuroscience and neuropsychiatric disorders. His work led to the development of diverse tracer kinetic modeling techniques and innovative imaging systems like NeuroEXPLORER.

New AI approach aims to predict radiation dose before therapy in advanced prostate cancer

A new machine-learning model uses pre-therapy PET/CT scans to estimate radiation dose to tumors and healthy organs, improving patient selection and reducing toxicity risk. The study's findings suggest a promising ability to predict post-therapy dosimetry, which may optimize treatment plans for individual patients.

SourceSociety of Nuclear Medicine and Molecular Imaging·JournalJournal of Nuclear Medicine·DateMay 30, 2026

Virtual-reality path integration for predicting risk of neurodegenerative diseases

Researchers found that impaired virtual reality path integration was closely tied to brain structure and biomarkers associated with neurodegeneration. This suggests that VR-based navigation errors may reveal hidden changes in the brain long before symptoms arise, making it a promising behavioral marker for preclinical Alzheimer's disease.

SourceFujita Health University·JournalAlzheimer s Research & Therapy·TypeObservational study·DateMay 27, 2026

The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: May 22, 2026

Researchers have made significant breakthroughs in nuclear medicine, with studies revealing uneven radiation doses in tiny kidney structures, improving survival rates for prostate cancer patients through targeted radiation therapy, and developing a new PET imaging approach to detect abdominal cancer spread. These advancements aim to im...

SourceSociety of Nuclear Medicine and Molecular Imaging·JournalJournal of Nuclear Medicine·DateMay 22, 2026

Brain Network Disorders article reviews the adoption of AI in brain cancer segmentation

A systematic review of AI models for meningioma segmentation reveals that better model architecture is the key driver of improved performance. The top models achieved high accuracy and efficiency, while future research focuses on making them more generalizable and efficient for real-world clinical settings.

SourceBrain Network Disorders Editorial Office·JournalBrain Network Disorders·TypeLiterature review·DateMay 19, 2026

Resting-state functional magnetic resonance imaging study on the effects of visual status on walking-related brain functions in healthy young adults

The study found that visual occlusion triggers brain compensation characterized by enhanced functional connectivity between the right precentral and middle frontal gyri. Walking activates multiple sensorimotor pathways to support basic locomotion, and visual occlusion further strengthens this connection as a compensatory mechanism.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeObservational study·DateMay 18, 2026

The Journal of Nuclear Medicine ahead-of-print tip sheet: May 15, 2026

Recent studies published in The Journal of Nuclear Medicine investigate the safety of kidney treatments, effectiveness of radioactive iodine for dialysis patients, and the use of new PET imaging agents to detect breast cancer spread. Researchers also explored emerging techniques like FAPI PET scans for improved detection and treatment ...

SourceSociety of Nuclear Medicine and Molecular Imaging·JournalJournal of Nuclear Medicine·DateMay 15, 2026

Comparing AI anatomy segmentation models when ground truth is missing

A recent study introduces a practical framework for comparing AI-based anatomy segmentation models in the absence of expert reference annotations. The work focuses on chest CT scans from the National Lung Screening Trial dataset and evaluates how consistently different open-source models label anatomical structures. Key findings includ...

SourceSPIE--International Society for Optics and Photonics·JournalJournal of Medical Imaging·DateMay 13, 2026

Novel theranostic approach for radioimmunotherapy achieves curative responses in colorectal cancer tumors

A new pretargeted radioimmunotherapy technique has been shown to be effective and safe in eradicating tumors from a preclinical colorectal cancer model. The multi-step theranostic approach delivers alpha-emitting radiation directly to tumors while limiting exposure to healthy tissues.

SourceSociety of Nuclear Medicine and Molecular Imaging·JournalJournal of Nuclear Medicine·DateApr 30, 2026

Cardiac CT scans see the future: Visualizing "invisible" heart risks

Researchers at Kumamoto University discovered that combining cardiac Computed Tomography (CT) scan markers can identify patients at highest risk for future heart failure and death. The 'delayed phase' scan detects localized scarring and subtle damage throughout the heart muscle, providing a synergistic view of heart health.

SourceKumamoto University·JournalEuropean Heart Journal - Cardiovascular Imaging·TypeObservational study·DateApr 21, 2026

Markers of lymphoma cancer relapse identified

A new study from the University of Missouri identified over 10 genetic or molecular markers that predict follicular lymphoma relapse early, allowing for targeted surveillance testing. This could improve patient outcomes, reduce unnecessary imaging tests, and lower healthcare costs.

SourceUniversity of Missouri-Columbia·JournalAmerican Journal of Clinical Oncology·TypeData/statistical analysis·DateMar 31, 2026

Lipid identification: Chemical fingerprint instead of dye

A new microscopy method can distinguish lipid species in living cells using mid-infrared illumination and optoacoustic detection, producing a unique spectral fingerprint. This approach eliminates the need for chemical labels, reducing stress on cells and enabling real-time lipid mapping.

The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: March 27, 2026

Recent studies published in The Journal of Nuclear Medicine have made significant advancements in the field. Researchers have developed a new tracer to detect active collagen turnover following myocardial infarction and evaluated folate-based radioconjugates for ovarian cancer imaging. Additionally, targeted radiotherapy shows promise ...

SourceSociety of Nuclear Medicine and Molecular Imaging·JournalJournal of Nuclear Medicine·DateMar 27, 2026

University of Houston BRAIN Center finds exposure to nature associated with reductions in negative emotions

A systematic review and meta-analysis of 33 studies found that nature exposure is associated with reductions in negative emotions and increases in positive emotions. Experts recommend integrating nature into urban design to promote brain health and treat mental illnesses.

SourceUniversity of Houston·JournalInternational Journal of Environmental Research and Public Health·DateMar 24, 2026

The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: March 20, 2026

The study investigated the link between heart attack-induced inflammation and cognitive decline, as well as the potential of PET-based metabolic tumor volume to predict CAR T-cell therapy outcomes. Additionally, researchers combined advanced imaging with genetic profiling to explore hidden metabolic patterns in recurrent brain cancer.

SourceSociety of Nuclear Medicine and Molecular Imaging·JournalJournal of Nuclear Medicine·DateMar 19, 2026

Can a specialized AI model steer doctors toward the right scan?

A specialized AI model, AMIR-GPT, has been developed to improve radiology guideline alignment, outperforming general purpose models in 33.3% of test responses. However, the model's performance varied across performance bands, and qualitative review revealed limitations, such as omissions and deviations from standard recommendations.

SourceIntelligent Medicine·JournalIntelligent Medicine·TypeComputational simulation/modeling·DateMar 17, 2026